Atlas Trials

A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus

Clinical trial NCT00657189 · COMPLETED

Trial details

NCT number
NCT00657189
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lupus Erythematosus, SystemicLupus
Start date
2008-07-01
Primary completion
2010-05-01
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.